The Lancet Haematology/X
Sep 2, 2025, 13:53
Cost-Effective Strategies to Reduce Anaemia Highlighted in The Lancet Haematology
The Lancet Haematology shared a post on X:
”September issue. Cost-effective targets to reduce anaemia, costs of anaemia interventions, ferritin-guided iron supplementation for donors, oral decitabine or cedazuridine for AML and MDS. Cover: Commission on global anaemia reduction targets.”
Read more here.
Find more on Hemostasis Today.
-
Dec 7, 2025, 15:20Deep Molecular Modeling for Type 2A VWD from Omid Seidizadeh
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights
-
Dec 6, 2025, 15:44Atul Gupta on Where The Healthcare Innovation is Headed
-
Dec 6, 2025, 15:22Nathan White on How Inflammation Contributes to Coagulopathy After Trauma
-
Dec 6, 2025, 15:02Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25
-
Dec 6, 2025, 14:08David Alderman: ASH25 is Live
-
Dec 6, 2025, 13:53Isabelle Mahé Presents The Proposals from INNOVTE CAT Working Group
-
Dec 6, 2025, 11:50Steve Tuplin on Roche’s Mission at ASH25
-
Dec 6, 2025, 11:13Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap